Bradley DeNardo
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Year:
2026
Year:
2025
Purpose: Comprehensive molecular profiling was used to define the genomic and immune landscapes of leiomyosarcomas (LMS) by anatomic subtypes, which have not been completely characterized. Experimental Design: A total of 1,115 LMS samples, categorized into uterine LMS (uLMS), retroperitoneal LMS, or other LMS (oLMS), underwent DNA/RNA sequencing (Caris Life Sciences). Genomic/transcriptomic profiles were compared across subtypes. Immune profiling was compared with melanoma ( n = 1,255), an immunogenic tumor. Insurance claims data were used to infer real-world outcomes with immune checkpoint inhibitors (ICI) in LMS. Results: uLMSs ( n = 701) were molecularly distinct from retroperitoneal LMSs ( n = 166) and oLMSs ( n = 248). RB1 mutations and MAP2K4 copy-number amplification were more common in non-uLMS. MED12 mutations were almost exclusive to uLMS. Traditional ICI response biomarkers (i.e., PD-L1) did not vary by anatomic site. Non-uLMS demonstrated upregulated immune-related gene sets, including IFN and inflammatory response pathways, and higher immune cell infiltration, especially CD8 + T cells and B cells (>2-fold increase, P n = 138), 29% of patients with LMS receiving ICI were treated >6 months, indicating potential clinical benefit. Conclusions: Comprehensive profiling suggested that uLMS represents a molecularly distinct disease from non-uLMS. Although traditional ICI response biomarkers were similar across anatomic subtypes, uLMSs were immune cold compared with non-uLMS. Signals for ICI responsiveness, such as high TIS and immune cell abundance, in some tumors suggest that further research into immunotherapies for LMS is warranted.
Year:
2025
Collaborators (9)
Don S. Dizon
Tufts Medical Center
Holly Lindsay
Associate Professor
University of Colorado Health
Margaret von Mehren
Professor
Fox Chase Cancer Center
Jaime F. Modiano
Alvin & June Perlman Professor of Animal Oncology
University of Minnesota
Vaia Florou
Associate Professor
Huntsman Cancer Institute
Andreas Seeber
Medical University of Innsbruck
Mohd Khushman
Professor
Washington University in St. Louis
Jonathan C. Trent
University of Miami Miller School of Medicine
Kimberly Stegmaier
Chair, Department of Pediatric Oncology
Dana-Farber Cancer Institute
Make your next move.
Prepare your application
Review drafts before you send them.